Open Access

3 more presentations in this session


Speaker: Professor A. Zambon (Padua, IT)


Reasons for a sequential treatment strategy in dyslipidemia.

Speaker: Professor E. Liberopoulos (Athens, GR)


Should we encourage earlier and broader use of combination therapies in dyslipidemia?

Speaker: Professor F. Schiele (Besancon, FR)


Access the full session

Sequential treatment strategy in dyslipidemia vs earlier use of combination therapies: decision-making factors

Speakers: Professor A. Zambon, Professor E. Liberopoulos, Professor F. Schiele

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

PAC use in daily clinical practice: a practical guide for fellows

19 March 2022

ESC Premium Access

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

27 August 2021

ESC Premium Access

EmDia - Empagliflozin and left ventricular diastolic function

27 August 2021

ESC 365 is supported by

logo Novo Nordisk